Dilek Satana

Prof. Dr. Dilek Satana

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2019 in Monatshefte für Chemie - Chemical Monthly
Verified
Journal Article
Closed access
PDF file
GCGökçe Cihan-Üstündağ
Gökçe Cihan-Üstündağ
LNLieve Naesens
Lieve Naesens
DSDilek Satana
Dilek Satana
GEGonca Erköse-Genç
Gonca Erköse-Genç
EMEmel Mataracı-Kara
Emel Mataracı-Kara
GÇGültaze Çapan
Gültaze Çapan

24 April 2015 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
GCGökçe Cihan-Üstündağ
Gökçe Cihan-Üstündağ
DSDilek Satana
Dilek Satana
GÖGül Özhan
Gül Özhan
GÇGültaze Çapan
Gültaze Çapan
A new series of indolylhydrazones (6) and indole-based 4-thiazolidinones (7, 8) have been designed, synthesized and screened for in vitro antitubercular activity against Mycobacterium tuberculosis H37Rv. 4-Thiazolidinone derivatives 7g-7j, 8g, 8h and 8j displayed notable antituberculosis (anti-TB) activity showing 99% inhibition at MIC values ranging from 6.25 to 25.0 µg/ml. Compounds 7g, 7h, 7i, 8h and 8j demonstrated anti-TB activity at concentrations 10-fold lower than those cytotoxic for the mammalian cell lines. The indolylhydrazone derivative 6b has also been evaluated for antiproliferative activity against human cancer cell lines at the National Cancer Institute (USA). Compound 6b showed an interesting anticancer profile against different human tumor-derived cell lines at sub-micromolar concentrations with obvious selectivity toward colon cancer cell line COLO 205.

1 July 2018
Verified
Journal Article
Closed access
GGGonca Erkose Genc
Gonca Erkose Genc
MDMelda Demir
Melda Demir
GYGorkem Yaman
Gorkem Yaman
BKBegum Kayar
Begum Kayar
FKFatih Koksal
Fatih Koksal
DSDilek Satana
Dilek Satana

23 December 2009 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
NKNalan Terzioğlu Klip
Nalan Terzioğlu Klip
GÇGültaze Çapan
Gültaze Çapan
AGAysel Gürsoy
Aysel Gürsoy
MUMeltem Uzun
Meltem Uzun
DSDilek Satana
Dilek Satana
Novel 1-[[4-(4-bromophenyl)-5-(2-furyl)-4H-1,2,4-triazole-3-yl]mercaptoacetyl]-4-alkyl/aryl-3-thiosemicarbazides (5–12) were synthesized by the reaction of 4-(4-bromophenyl)-5-(2-furyl)-4H-1,2,4-triazole-3-ylmercaptoacetylhydrazide (4) with substituted isothiocyanates. Cyclodehydration of thiosemicarbazides with concentrated sulfuric acid yielded 2-[4-(4-bromophenyl)-5-(2-furyl)-4H-1,2,4-triazole-3-yl]mercaptomethyl-5-alkyl/arylamino-1,3, 4-thiadiazoles (13–17). The new compounds were evaluated for in vitro antifungal activity using the microdilution method. The tested compounds showed varying degrees of activity against Microsporum gypseum NCPF-580, Microsporum canis, Trichophyton mentagrophytes, Trichophyton rubrum, and Candida albicans ATCC 10231 (MIC 8–4 μg/mL).

30 July 2012 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
NGNuray Ulusoy Güzeldemirci
Nuray Ulusoy Güzeldemirci
DSDilek Satana
Dilek Satana
ÖKÖmer Küçükbasmacı
Ömer Küçükbasmacı
In this work, we reported the synthesis and evaluation of antibacterial and antifungal activities of three new compound series obtained from 6-(phenyl/4-chlorophenyl)imidazo[2,1-b]thiazole-3-acetic acid hydrazide: 2-{[6-(phenyl/4-chlorophenyl)imidazo[2,1-b]thiazol-3-yl]acetyl}-N-alkyl/arylhydrazinecarbothioamides (2a–d), 4-alkyl/aryl-2,4-dihydro-5-{[6-(phenyl/4-chlorophenyl)imidazo[2,1-b]thiazol-3-yl]methyl}-3H-1,2,4-triazole-3-thiones (3a–n), and 2-alkyl/arylamino-5-{[6-(phenyl/4-chlorophenyl)imidazo[2,1-b]thiazol-3-yl]methyl}-1,3,4-thiadiazoles (4a–g). The newly synthesized compounds were characterized by IR, 1H NMR, 13C NMR (APT), mass and elemental analysis. Their antibacterial and antifungal activities were evaluated against Staphylococcus aureus ATCC 29213, Pseudomonas aeruginosa ATCC 27853, Escherichia coli ATCC 25922, Candida albicans ATCC 10231, C. parapsilosis ATCC 22019, C. krusei ATCC 6258, Trichophyton mentagrophytes var. erinacei NCPF 375, Microsporum gypseum NCPF 580, and T. tonsurans NCPF 245. 3c, 3f, 3m, 3n, and 4e showed the highest antibacterial activity. Particularly 3c, 3f, 3g, 3k, 3n, 4a, 4e, and 4g showed the highest antifungal activity against tested fungi.

13 August 2014 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
DSDilek Satana
Dilek Satana
GGGonca Erkose Genc
Gonca Erkose Genc
ZTZeynep Tamay
Zeynep Tamay
MUMeltem Uzun
Meltem Uzun
NGNermin Guler
Nermin Guler
ZEZayre Erturan
Zayre Erturan
Isolation of mycobacteria in cystic fibrosis (CF) patients is increasingly being reported. Because of having long term antimicrobial treatment, CF patients are at risk of pulmonary infection with especially resistant nontuberculous mycobacteria (NTM) strains. The aim of the present study is to determine the prevalence of mycobacterium spp. and antimicrobial susceptibility in Turkish CF patients.